Medical - Devices
Compare Stocks
2 / 10Stock Comparison
INMD vs ISRG
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Instruments & Supplies
INMD vs ISRG — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Medical - Devices | Medical - Instruments & Supplies |
| Market Cap | $861M | $160.44B |
| Revenue (TTM) | $370M | $10.58B |
| Net Income (TTM) | $94M | $2.98B |
| Gross Margin | 78.5% | 66.3% |
| Operating Margin | 23.0% | 30.5% |
| Forward P/E | 9.4x | 43.7x |
| Total Debt | $13M | $303M |
| Cash & Equiv. | $303M | $3.37B |
INMD vs ISRG — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| InMode Ltd. (INMD) | 100 | 92.7 | -7.3% |
| Intuitive Surgical,… (ISRG) | 100 | 233.6 | +133.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: INMD vs ISRG
Each card shows where this stock fits in a portfolio — not just who wins on paper.
INMD is the clearest fit if your priority is valuation efficiency.
- PEG 0.95 vs ISRG's 2.01
- Lower P/E (9.4x vs 43.7x), PEG 0.95 vs 2.01
- -5.0% vs ISRG's -14.8%
ISRG carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- beta 1.02
- Rev growth 20.5%, EPS growth 22.6%, 3Y rev CAGR 17.4%
- 5.6% 10Y total return vs INMD's 100.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.5% revenue growth vs INMD's -6.2% | |
| Value | Lower P/E (9.4x vs 43.7x), PEG 0.95 vs 2.01 | |
| Quality / Margins | 28.2% margin vs INMD's 25.3% | |
| Stability / Safety | Beta 1.02 vs INMD's 1.04, lower leverage | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | -5.0% vs ISRG's -14.8% | |
| Efficiency (ROA) | 14.8% ROA vs INMD's 12.9%, ROIC 15.0% vs 13.5% |
INMD vs ISRG — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
INMD vs ISRG — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
ISRG leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ISRG is the larger business by revenue, generating $10.6B annually — 28.6x INMD's $370M. Profitability is closely matched — net margins range from 28.2% (ISRG) to 25.3% (INMD). On growth, ISRG holds the edge at +23.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $370M | $10.6B |
| EBITDAEarnings before interest/tax | $86M | $3.8B |
| Net IncomeAfter-tax profit | $94M | $3.0B |
| Free Cash FlowCash after capex | $89M | $2.8B |
| Gross MarginGross profit ÷ Revenue | +78.5% | +66.3% |
| Operating MarginEBIT ÷ Revenue | +23.0% | +30.5% |
| Net MarginNet income ÷ Revenue | +25.3% | +28.2% |
| FCF MarginFCF ÷ Revenue | +24.1% | +26.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.1% | +23.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -63.2% | +18.8% |
Valuation Metrics
INMD leads this category, winning 7 of 7 comparable metrics.
Valuation Metrics
At 9.5x trailing earnings, INMD trades at a 83% valuation discount to ISRG's 57.4x P/E. Adjusting for growth (PEG ratio), INMD offers better value at 0.96x vs ISRG's 2.64x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $861M | $160.4B |
| Enterprise ValueMkt cap + debt − cash | $572M | $157.4B |
| Trailing P/EPrice ÷ TTM EPS | 9.50x | 57.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.41x | 43.67x |
| PEG RatioP/E ÷ EPS growth rate | 0.96x | 2.64x |
| EV / EBITDAEnterprise value multiple | 6.64x | 43.44x |
| Price / SalesMarket cap ÷ Revenue | 2.32x | 15.94x |
| Price / BookPrice ÷ Book value/share | 1.30x | 9.13x |
| Price / FCFMarket cap ÷ FCF | 10.22x | 64.42x |
Profitability & Efficiency
ISRG leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
ISRG delivers a 16.9% return on equity — every $100 of shareholder capital generates $17 in annual profit, vs $15 for INMD. ISRG carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to INMD's 0.02x. On the Piotroski fundamental quality scale (0–9), ISRG scores 6/9 vs INMD's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +14.5% | +16.9% |
| ROA (TTM)Return on assets | +12.9% | +14.8% |
| ROICReturn on invested capital | +13.5% | +15.0% |
| ROCEReturn on capital employed | +12.1% | +16.5% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 6 |
| Debt / EquityFinancial leverage | 0.02x | 0.02x |
| Net DebtTotal debt minus cash | -$289M | -$3.1B |
| Cash & Equiv.Liquid assets | $303M | $3.4B |
| Total DebtShort + long-term debt | $13M | $303M |
| Interest CoverageEBIT ÷ Interest expense | — | — |
Total Returns (Dividends Reinvested)
ISRG leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ISRG five years ago would be worth $16,086 today (with dividends reinvested), compared to $3,608 for INMD. Over the past 12 months, INMD leads with a -5.0% total return vs ISRG's -14.8%. The 3-year compound annual growth rate (CAGR) favors ISRG at 14.2% vs INMD's -27.0% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -8.2% | -19.6% |
| 1-Year ReturnPast 12 months | -5.0% | -14.8% |
| 3-Year ReturnCumulative with dividends | -61.1% | +49.0% |
| 5-Year ReturnCumulative with dividends | -63.9% | +60.9% |
| 10-Year ReturnCumulative with dividends | +100.1% | +556.9% |
| CAGR (3Y)Annualised 3-year return | -27.0% | +14.2% |
Risk & Volatility
Evenly matched — INMD and ISRG each lead in 1 of 2 comparable metrics.
Risk & Volatility
ISRG is the less volatile stock with a 1.02 beta — it tends to amplify market swings less than INMD's 1.04 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INMD currently trades 81.2% from its 52-week high vs ISRG's 74.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.04x | 1.02x |
| 52-Week HighHighest price in past year | $16.74 | $603.88 |
| 52-Week LowLowest price in past year | $12.72 | $427.84 |
| % of 52W HighCurrent price vs 52-week peak | +81.2% | +74.8% |
| RSI (14)Momentum oscillator 0–100 | 56.0 | 42.2 |
| Avg Volume (50D)Average daily shares traded | 788K | 1.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates INMD as "Buy" and ISRG as "Buy". Consensus price targets imply 37.8% upside for ISRG (target: $623) vs 17.7% for INMD (target: $16).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $16.00 | $622.60 |
| # AnalystsCovering analysts | 11 | 55 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +14.8% | +1.4% |
ISRG leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). INMD leads in 1 (Valuation Metrics). 1 tied.
INMD vs ISRG: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is INMD or ISRG a better buy right now?
For growth investors, Intuitive Surgical, Inc.
(ISRG) is the stronger pick with 20. 5% revenue growth year-over-year, versus -6. 2% for InMode Ltd. (INMD). InMode Ltd. (INMD) offers the better valuation at 9. 5x trailing P/E (9. 4x forward), making it the more compelling value choice. Analysts rate InMode Ltd. (INMD) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — INMD or ISRG?
On trailing P/E, InMode Ltd.
(INMD) is the cheapest at 9. 5x versus Intuitive Surgical, Inc. at 57. 4x. On forward P/E, InMode Ltd. is actually cheaper at 9. 4x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: InMode Ltd. wins at 0. 95x versus Intuitive Surgical, Inc. 's 2. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — INMD or ISRG?
Over the past 5 years, Intuitive Surgical, Inc.
(ISRG) delivered a total return of +60. 9%, compared to -63. 9% for InMode Ltd. (INMD). Over 10 years, the gap is even starker: ISRG returned +556. 9% versus INMD's +100. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — INMD or ISRG?
By beta (market sensitivity over 5 years), Intuitive Surgical, Inc.
(ISRG) is the lower-risk stock at 1. 02β versus InMode Ltd. 's 1. 04β — meaning INMD is approximately 2% more volatile than ISRG relative to the S&P 500. On balance sheet safety, Intuitive Surgical, Inc. (ISRG) carries a lower debt/equity ratio of 2% versus 2% for InMode Ltd. — giving it more financial flexibility in a downturn.
05Which is growing faster — INMD or ISRG?
By revenue growth (latest reported year), Intuitive Surgical, Inc.
(ISRG) is pulling ahead at 20. 5% versus -6. 2% for InMode Ltd. (INMD). On earnings-per-share growth, the picture is similar: Intuitive Surgical, Inc. grew EPS 22. 6% year-over-year, compared to -36. 4% for InMode Ltd.. Over a 3-year CAGR, ISRG leads at 17. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — INMD or ISRG?
Intuitive Surgical, Inc.
(ISRG) is the more profitable company, earning 28. 4% net margin versus 25. 3% for InMode Ltd. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ISRG leads at 29. 3% versus 23. 0% for INMD. At the gross margin level — before operating expenses — INMD leads at 78. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is INMD or ISRG more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, InMode Ltd. (INMD) is the more undervalued stock at a PEG of 0. 95x versus Intuitive Surgical, Inc. 's 2. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, InMode Ltd. (INMD) trades at 9. 4x forward P/E versus 43. 7x for Intuitive Surgical, Inc. — 34. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ISRG: 37. 8% to $622. 60.
08Which pays a better dividend — INMD or ISRG?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is INMD or ISRG better for a retirement portfolio?
For long-horizon retirement investors, Intuitive Surgical, Inc.
(ISRG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 02), +556. 9% 10Y return). Both have compounded well over 10 years (ISRG: +556. 9%, INMD: +100. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between INMD and ISRG?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: INMD is a small-cap deep-value stock; ISRG is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.